Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Antepartum periodontitis treatment and risk of offspring screening positive for autism spectrum disorder

  • Carl Bose
  • , Gregory C. Valentine
  • , Kamaira Philips
  • , Kim Boggess
  • , Kevin Moss
  • , Silvana P. Barros
  • , Julie Marchesan
  • , Di Wu
  • , Thomas M. O’Shea
  • , Myriam Peralta-Carcelen
  • , Ricki Goldstein
  • , Rajam Ramamurthy
  • , James D. Beck

Producción científica: Articlerevisión exhaustiva

2 Citas (Scopus)

Resumen

Background: To evaluate if treating maternal periodontal disease, a pro-inflammatory condition, during pregnancy (intervention) compared to after pregnancy (control) reduces the likelihood of offspring screening positive for autism spectrum disorder (ASD). Methods: In a follow-up study to the MOTOR randomized trial, we compared rates of positive screens on the Modified Checklist for Autism in Toddlers (M-CHAT) among n = 306 two-year-old toddlers and correlated findings to maternal and cord blood pro-inflammatory interleukin-6 (IL-6). Results: Toddlers in the intervention group had decreased risk of a positive M-CHAT screen (adjusted RR = 0.53, 95% CI 0.29–0.99). Toddlers screening positive compared to negative had higher mean IL-6 in cord blood (1.58 ± 1.14 vs. 1.09 ± 0.72 p = 0.001) and maternal IL-6 change from baseline (1.30 ± 0.61 vs 0.96 ± 0.62 p = 0.03). Conclusions: Treating periodontal disease during pregnancy reduced risk of a positive ASD screen. M-CHAT positivity was associated with increased IL-6 in maternal and cord blood. Clinical trial: Trial Registration numbers: Clinicaltrials.gov NCT03423836.

Idioma originalEnglish
Páginas (desde-hasta)470-476
Número de páginas7
PublicaciónJournal of Perinatology
Volumen43
N.º4
DOI
EstadoPublished - abr 2023

Nota bibliográfica

Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature America, Inc.

Financiación

We want to extend our sincerest gratitude to Dr. Steven Offenbacher, the primary investigator of the MOTOR trial. The dental, medical, and scientific communities all had a significant loss with Dr. Offenbacher’s passing. We want to acknowledge the NIH and the MOTOR and MOTORKids investigators and teams. This study was supported by the NIDCR (3U01DE014577) and the NCRR (RR00046, UL1RR025747). We acknowledge the additional grant support of the NIH K01DE027087 (PI JTM) and K23HD105929 (PI GV). We want to extend our sincerest gratitude to Dr. Steven Offenbacher, the primary investigator of the MOTOR trial. The dental, medical, and scientific communities all had a significant loss with Dr. Offenbacher’s passing. We want to acknowledge the NIH and the MOTOR and MOTORKids investigators and teams. This study was supported by the NIDCR (3U01DE014577) and the NCRR (RR00046, UL1RR025747). We acknowledge the additional grant support of the NIH K01DE027087 (PI JTM) and K23HD105929 (PI GV).

FinanciadoresNúmero del financiador
Toyota Motor
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research3U01DE014577
National Institute of Dental and Craniofacial Research
National Center for Research ResourcesK23HD105929, RR00046, UL1RR025747, K01DE027087
National Center for Research Resources

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health
    • Obstetrics and Gynecology

    Huella

    Profundice en los temas de investigación de 'Antepartum periodontitis treatment and risk of offspring screening positive for autism spectrum disorder'. En conjunto forman una huella única.

    Citar esto